An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
| Status: | Recruiting |
|---|---|
| Conditions: | Blood Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 10/20/2018 |
| Start Date: | June 30, 2016 |
| End Date: | March 31, 2020 |
| Contact: | Amgen Call Center |
| Email: | medinfo@amgen.com |
| Phone: | 866-572-6436 |
An Observational Study of Patients With Philadelphia Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
A retrospective chart review study of Philadelphia chromosome-negative R/R ALL patients in
the US.
the US.
Inclusion Criteria
-Medical records of patients initiating treatment for Ph- R/R ALL at participating clinical
centers in the US between January 2013 and March 2019 will be eligible for inclusion.
Exclusion Criteria
- Medical records of patients with Ph+ ALL will be excluded.
- If informed consent is required, medical records of patients who do not provide
informed consent will be excluded.
We found this trial at
17
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials